Investors Grab OVID 25.0% Cheaper Than Its Secondary Stock Offering
November 25, 2020 at 10:04 AM EST
Looking back to 92 days ago, Ovid Therapeutics Inc (OVID) priced a 6,250,000 share secondary stock offering at $8.00 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go up over the course of time..